TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer

We have explored a unique combination therapy for metastatic colorectal cancer. This strategy combines a potent and new oncolytic poxvirus expressing a membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (TRAIL or TNFSF10) and oxaliplatin (Ox) chemotherapy. We hypothesized that TR...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ziauddin, Mohammed F, Guo, Z. Sheng, O'Malley, Mark E., Austin, Frances, Popovic, Petar J., Kavanagh, Maihgan A., Li, Jun, Sathaiah, Magesh, Thirunavukkarasu, Prag, Fang, Bingliang, Lee, Yong J., Bartlett, David L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3250063/
https://ncbi.nlm.nih.gov/pubmed/20182517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2010.5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak